The Noncatalytic Amino Terminus of Mitogen-Activated Protein Kinase Phosphatase 1 Directs Nuclear Targeting and Serum Response Element Transcriptional Regulation
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is an immediate-early gene comprised of a dual-specificity phosphatase domain and a noncatalytic NH(2) terminus. Here, we show that the NH(2) terminus of MKP-1, containing the cdc25 homology domains A (CH2A) and B (CH2B), mediates MKP-1 nuclear targeting and modulates MAPK-mediated gene expression. An LXXLL motif which is known to mediate protein-protein interactions with nuclear-targeted hormone receptors was identified proximal to the CH2A domain of MKP-1. The NH(2) terminus alone of MKP-1 containing this LXXLL motif was sufficient to direct nuclear targeting, and mutating this motif to LXXAA resulted in the exclusion of MKP-1 from the nucleus. We found that the LXXLL motif proximal to the CH2A domain was present in other nuclear-localized MKPs but was absent in MKPs that localized to the cytoplasm. These data suggest that this LXXLL motif confers nuclear targeting properties to the MKPs. The NH(2) terminus of MKP-1 was also found to inhibit the activation of the serum response element (SRE) by preventing MAPK-mediated phosphorylation of the regulatory serine 383 residue on Elk-1. Moreover, we show that MKP-1 plays a major role in the attenuation of serum-induced SRE activity, since MKP-1 null fibroblasts exhibited enhanced SRE activity in response to serum compared with wild-type fibroblasts. The NH(2) terminus of MKP-1, when reconstituted into MKP-1 null fibroblasts to levels similar to endogenous MKP-1 following serum stimulation, reduced serum-mediated SRE activity. Collectively, these data reveal novel roles for the NH(2) terminus of MKP-1 in nuclear targeting and transcriptional regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128 · cited 3×
“To test the possibility that this LXXLL sequence confers nuclear targeting to MKP-1, we mutated the last two leucines to alanines (LXXLL3LXXAA) in order to disrupt the functionality of this motif (17, 20, 27).”
BackgroundSun, H., Charles, C. H., Lau, L. F., & Tonks, N. K. (1993) · Cell · doi:10.1016/0092-8674(93)90383-2 · Cited by 1,156 · cited 2×
“The transcriptional induction of MKP-1 occurs following activation of the MAPKs, and it has been shown that both p38 MAPK and Erk can stimulate MKP-1 gene expression (2, 8, 10, 23, 36 ).”
BackgroundThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · cited 3×
“We utilized the Elk-1 system to test this, since MAPK phosphorylates Elk-1, leading to its activation (33, 47).”
BackgroundMethodA conserved docking motif in MAP kinases common to substrates, activators and regulators
Tanoue, T., Adachi, M., Moriguchi, T., & Nishida, E. (2000) · Nature Cell Biology · doi:10.1038/35000065 · Cited by 816
Li, Q., Yang, S., Maeda, Y., Sladek, F. M., Sharrocks, A. D., & Martins‐Green, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg028 · Cited by 158 · cited 1×
“We found that the NH2 terminus of MKP-1 when overexpressed failed to affect MAPK activation, but it inhibited the ability of MAPK to phosphorylate Elk-1 on serine 383, the critical site for Elk-1 activation (25).”
BackgroundSolution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3
Farooq, A., Chaturvedi, G., Mujtaba, S., Plotnikova, O., Zeng, L., Dhalluin, C., Ashton, R., & Zhou, M.-M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00186-1 · Cited by 119 · cited 1×
“Similarly, MAPK binding to the common MAPK interaction motif on MKP-3 induces a conformational change in the COOH terminus of the phosphatase that also enhances its catalytic activity (4, 13 , 35).”
BackgroundThe mechanism of phosphorylation‐inducible activation of the ETS‐domain transcription factor Elk‐1
Yang, S., Shore, P., Willingham, N., Lakey, J. H., & Sharrocks, A. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5666 · Cited by 112 · cited 1×
“The consequences of this phosphorylation at serine 383 within the C terminus result in the relief of an inhibitory intramolecular interaction within Elk-1 that enhances its DNA binding through conformational modulation of the N terminus ( 48 ).”
BackgroundBARDWELL, A. J., ABDOLLAHI, M., & BARDWELL, L. (2003) · Biochemical Journal · doi:10.1042/bj20021806 · Cited by 97
Cited by
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777
“Unlike DUSP10/MKP-5, which is found in both the nucleus and the cytoplasm (Tanoue et al., 1999), DUSP1/MKP-1 is a nuclear enzyme and may act differentially to regulate nuclear but not cytoplasmic MAPK functions (Wu et al., 2005).”
BackgroundMAPK phosphatases — regulating the immune response
Liu, Y., Shepherd, E. G., & Nelin, L. D. (2007) · Nature Reviews Immunology · doi:10.1038/nri2035 · Cited by 679
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569
Self-citationBoutros, T., Chevet, E., & Metrakos, P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00106 · Cited by 545
Dual‐specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Caunt, C. J., & Keyse, S. M. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08716.x · Cited by 535
Metadata
- Authors
- Wu, J. J., Zhang, L., & Bennett, A. M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2005-06
- Volume
- 25
- Issue
- 11
- Pages
- 4792-4803
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2108343283
- Cited by
- 68
- References
- 8
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.